Literature DB >> 25210121

TRIF signaling drives homeostatic intestinal epithelial antimicrobial peptide expression.

Silvia Stockinger1, Claudia U Duerr2, Marcus Fulde2, Tamas Dolowschiak3, Johanna Pott2, Ines Yang2, Daniel Eibach2, Fredrik Bäckhed4, Shizuo Akira5, Sebastian Suerbaum2, Martijn Brugman6, Mathias W Hornef7.   

Abstract

Recent results indicate a significant contribution of innate immune signaling to maintain mucosal homeostasis, but the precise underlying signal transduction pathways are ill-defined. By comparative analysis of intestinal epithelial cells isolated from conventionally raised and germ-free mice, as well as animals deficient in the adaptor molecules MyD88 and TRIF, the TLR3 and TLR4, as well as the type I and III IFN receptors, we demonstrate significant TLR-mediated signaling under homeostatic conditions. Surprisingly, homeostatic expression of Reg3γ and Paneth cell enteric antimicrobial peptides critically relied on TRIF and, in part, TLR3 but was independent of IFN receptor signaling. Reduced antimicrobial peptide expression was associated with significantly lower numbers of Paneth cells and a reduced Paneth cell maturation and differentiation factor expression in TRIF mutant compared with wild-type epithelium. This phenotype was not transferred to TRIF-sufficient germ-free animals during cohousing. Low antimicrobial peptide expression in TRIF-deficient mice caused reduced immediate killing of orally administered bacteria but was not associated with significant alterations in the overall composition of the enteric microbiota. The phenotype was rapidly restored in a TRIF-independent fashion after transient epithelial damage. Our results identify TRIF signaling as a truly homeostatic pathway to maintain intestinal epithelial barrier function revealing fundamental differences in the innate immune signaling between mucosal homeostasis and tissue repair.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25210121     DOI: 10.4049/jimmunol.1302708

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  TLR5 expression in the small intestine depends on the adaptors MyD88 and TRIF, but is independent of the enteric microbiota.

Authors:  Inês Brandão; Nives Hörmann; Sven Jäckel; Christoph Reinhardt
Journal:  Gut Microbes       Date:  2015-04-29

2.  TLR signaling modulates side effects of anticancer therapy in the small intestine.

Authors:  Magdalena Frank; Eva Maria Hennenberg; Annette Eyking; Michael Rünzi; Guido Gerken; Paul Scott; Julian Parkhill; Alan W Walker; Elke Cario
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Unexpected Roles for Toll-Like Receptor 4 and TRIF in Intraocular Infection with Gram-Positive Bacteria.

Authors:  Salai Madhumathi Parkunan; C Blake Randall; Phillip S Coburn; Roger A Astley; Rachel L Staats; Michelle C Callegan
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

4.  Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium.

Authors:  Jacob A Van Winkle; Stefan T Peterson; Elizabeth A Kennedy; Michael J Wheadon; Harshad Ingle; Chandni Desai; Rachel Rodgers; David A Constant; Austin P Wright; Lena Li; Maxim N Artyomov; Sanghyun Lee; Megan T Baldridge; Timothy J Nice
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

Review 5.  The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Authors:  Timothy J Nice; Bridget A Robinson; Jacob A Van Winkle
Journal:  Trends Microbiol       Date:  2017-11-17       Impact factor: 17.079

6.  Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist.

Authors:  Dilara Islam; Eric Lombardini; Nattaya Ruamsap; Rawiwan Imerbsin; Patchariya Khantapura; Ian Teo; Pimmnapar Neesanant; Siriphan Gonwong; Kosol Yongvanitchit; Brett E Swierczewski; Carl J Mason; Sunil Shaunak
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

7.  Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period.

Authors:  Natalia Torow; Kai Yu; Kasra Hassani; Jenny Freitag; Olga Schulz; Marijana Basic; Anne Brennecke; Tim Sparwasser; Norbert Wagner; André Bleich; Matthias Lochner; Siegfried Weiss; Reinhold Förster; Oliver Pabst; Mathias W Hornef
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

8.  Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.

Authors:  John David Spencer; Ashley R Jackson; Birong Li; Christina B Ching; Martin Vonau; Robert S Easterling; Andrew L Schwaderer; Kirk M McHugh; Brian Becknell
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

9.  Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice.

Authors:  Danica Bajic; Adrian Niemann; Anna-Katharina Hillmer; Raquel Mejias-Luque; Sena Bluemel; Melissa Docampo; Maja C Funk; Elena Tonin; Michael Boutros; Bernd Schnabl; Dirk H Busch; Tsuyoshi Miki; Roland M Schmid; Marcel R M van den Brink; Markus Gerhard; Christoph K Stein-Thoeringer
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

10.  WISP1 mediates hepatic warm ischemia reperfusion injury via TLR4 signaling in mice.

Authors:  Yao Tong; Xi-Bing Ding; Zhi-Xia Chen; Shu-Qing Jin; Xiang Zhao; Xin Wang; Shu-Ya Mei; Xi Jiang; Lingyu Wang; Quan Li
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.